...
首页> 外文期刊>Clinical Laboratory >Thromboprophylaxis with low-molecularweight heparin after cesarean delivery
【24h】

Thromboprophylaxis with low-molecularweight heparin after cesarean delivery

机译:剖宫产术后低分子肝素预防血栓形成

获取原文
获取原文并翻译 | 示例
           

摘要

Venous thromboembolism (VTE) is the leading cause of maternal mortality and morbidity in the developed world. Pregnancy is associated with an up to 10-fold increase in the risk of VTE compared with non-pregnant women, with the highest incidence during the post-partum period. Cesarean delivery further raises the incidence of VTE by up to 22 times with the highest risk reported after an emergency procedure. In the mean time, a continuous rise in the use of cesarean delivery has been widely reported in developed countries (in the United States nearly 30% of births were delivered by this route in 2004). Nevertheless, there is some evidence that thromboprophylaxis using unfraction-ated heparin after caesarean delivery was potentially more harmful than beneficial. However, this may be due to negative side-effects of unfractionated heparin such as heparin-induced thrombocytopenia and relatively high rates of bleeding complications.
机译:静脉血栓栓塞症(VTE)是发达国家孕产妇死亡率和发病率的主要原因。与未怀孕的妇女相比,怀孕可使VTE的风险增加多达10倍,并且在产后期间发生率最高。剖宫产进一步将VTE的发生率提高了22倍,在紧急手术后报道的最高风险。同时,在发达国家广泛报道了剖宫产的使用持续增加(在美国,2004年通过这种途径剖宫产的人数接近30%)。但是,有一些证据表明,剖腹产后使用普通肝素进行血栓预防可能有害无益。但是,这可能是由于普通肝素的不良副作用(例如肝素诱导的血小板减少症)和较高的出血并发症发生率所致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号